-
Erekat NS. Apoptosis and its therapeutic implications in neurodegenerative diseases. Clinical Anatomy. 2022 Jan;35(1):65-78.
-
Stoker, Thomas B., and Julia C. Greenland. "Parkinson’s disease: pathogenesis and clinical aspects [internet]." (2018).
-
Dallapiazza, Robert F., Philippe De Vloo, Anton Fomenko, Darren J. Lee, Clement Hamani, Renato P. Munhoz, M. Hodaie, A. M. Lozano, Alfonso Fasano, and Suneil K. Kalia. "Parkinson’s Disease: Pathogenesis and Clinical Aspects." (2018).
-
DUBOIS, Bruno; PILLON, Bernard. Cognitive deficits in Parkinson’s disease. Journal of neurology, 1996, 244.1: 2-8.
-
EMRE, Murat. Dementia associated with Parkinson's disease. The Lancet Neurology, 2003, 2.4: 229-237.
-
LEROY, Elisabeth, et al. The ubiquitin pathway in Parkinson's disease. Nature, 1998, 395.6701: 451-452.
-
POSTUMA, Ronald B., et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement disorders, 2015, 30.12: 1591-1601.
-
VON CAMPENHAUSEN, Sonja, et al. Prevalence and incidence of Parkinson's disease in Europe. European Neuropsycho-pharmacology, 2005, 15.4: 473-490.
-
ABOU-SLEIMAN, Patrick M.; MUQIT, Miratul MK; WOOD, Nicholas W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nature Reviews Neuroscience, 2006, 7.3: 207-219.
-
CHAUDHURI, K. Ray; HEALY, Daniel G.; SCHAPIRA, Anthony HV. Non-motor symptoms of Parkinson's disease: diagnosis and management. The Lancet Neurology, 2006, 5.3: 235-245.